The Short Version
This page is a curated directory of registered clinical trials that study adipose-derived and mesenchymal stem cells, organized by medical condition. Each entry links directly to its record on ClinicalTrials.gov, the official government registry, where you can see the current phase, status, eligibility, and contacts. Every trial listed uses a real registration number. It is important to be clear about what this is and is not. It is an educational research reference, not a list of available treatments and not medical advice. These cell therapies are investigational and are not FDA-approved for the conditions shown. A trial being registered does not mean it is proven, safe, or effective. And banking your own tissue with SaveMyFat does not enroll you in any of these studies or make you eligible for one. Enrollment is controlled by each trial’s investigators.
Important: This directory is for education only. It is not medical advice, not a recommendation, and not an endorsement of any study or sponsor. The cell therapies listed are investigational and are not FDA-approved to diagnose, treat, cure, or prevent any disease. Trial details change; confirm the current status and eligibility on each linked ClinicalTrials.gov record and with the study team. SaveMyFat is a connector for adipose tissue preservation. It is not a clinical trial sponsor, it does not enroll patients, and banking does not guarantee eligibility, access, or benefit. Talk with your own licensed physician before acting on anything here.
How to Use This Directory
Almost no adipose banking company keeps a real, sourced trial directory on its own site. We built one because it is genuinely useful, and because it models the right way to read this research: skeptically, and straight from the primary source. Use the table below to see, by condition, which registered studies exist, then click any NCT number to open the official record and confirm the details yourself.
For background on how trials work and how to separate legitimate research from marketing, see our guides to what clinical trials for regenerative medicine are, what the ClinicalTrials.gov phases actually mean, and how to find legitimate clinical trials. This page reflects the landscape as of July 2026 and is reviewed quarterly.
How to Read a Clinical Trial Listing
Every entry has the same parts, and knowing them helps you read the table and the linked record with a clear eye:
- NCT number: the unique ID for the study on ClinicalTrials.gov. Always confirm a trial by this number.
- Phase: roughly, Phase 1 tests safety, Phase 2 tests safety and early effect, Phase 3 tests effectiveness in larger groups. Later phase is not proof of benefit.
- Status: where the study is in its life cycle (recruiting, active and not recruiting, completed). This changes often, so verify it on the live record.
- Sponsor: the institution or company running the study.
- Cell source: whether the study uses your own cells (autologous) or donor cells (allogeneic), and whether they are adipose-derived or another mesenchymal source.
One more habit worth building: be skeptical of any clinic that calls an expensive, ready-to-buy treatment a clinical trial. Legitimate trials are registered with an NCT number, list their eligibility and sponsor openly, and are overseen by an ethics board. They generally do not charge patients for the investigational product itself. If something is marketed as a trial but asks for large out-of-pocket payments and promises results, treat that as a warning sign. Our guide on how to spot fake stem cell clinics walks through the red flags.
Trial Directory by Condition
The table below groups registered studies by condition category. Every entry links to its official ClinicalTrials.gov record, and the status shown is a July 2026 snapshot that you should re-check on the record, since trial status changes over time. This is a research snapshot, not a treatment offering. A short note on what each category covers, then the table.
Orthopedics. Orthopedic applications, especially knee osteoarthritis, are among the most studied uses of adipose-derived cells. Trials look at whether an injection of a person’s own cells affects joint pain and function. Results so far are mixed and preliminary, and no such use is FDA-approved.
Autoimmune and inflammatory. Researchers are studying whether mesenchymal and adipose-derived cells can calm an overactive immune response in conditions such as rheumatoid arthritis. This work is early stage, and these are investigational studies, not approved treatments.
Neurology. Neurological trials, including several at Mayo Clinic, are testing adipose-derived cells delivered into the spinal fluid for conditions such as multiple system atrophy and ALS. These are difficult diseases, the studies are early phase, and none has produced an approved therapy.
Organ disease. Heart, kidney, and lung studies use mesenchymal cells from adipose and other sources. Some, such as a Danish heart failure trial, have completed; others are ongoing. As everywhere on this page, completion is not the same as approval.
Dermatology and aesthetics. Skin research explores whether adipose-derived cells affect inflammatory skin conditions such as atopic dermatitis. This is an active but early area, and marketed aesthetic stem cell products are frequently unproven and should be treated with caution.
Gastrointestinal. The most advanced GI work involves adipose-derived cells for the complex perianal fistulas that can accompany Crohn’s disease. One adipose product, darvadstrocel, reached approval in Europe for that narrow use, though a later confirmatory trial did not meet its goals, a reminder that even advanced programs can fall short.
Status shown reflects the ClinicalTrials.gov record as of July 2026, confirmed against the registry. Trial status changes over time, so open any linked record for the current status before relying on it. This directory is educational and does not recommend or endorse any trial.
This is not an exhaustive list. Many more studies exist and new ones register regularly. Browse the full registry at ClinicalTrials.gov, and read our condition overviews for orthopedics, autoimmune and inflammatory conditions, neurology, kidney, heart, and lung, and hair and skin.
How SaveMyFat's Content Relates to These Trials
To be completely clear: SaveMyFat does not run any of these trials, does not enroll patients in them, and cannot get you into one. We are a connector for adipose tissue preservation. We maintain this directory as an educational resource so that patients and physicians can find and evaluate real research in one place.
Banking is a separate step from any treatment or trial. Preserving your own tissue does not make you eligible for a study, does not reserve a spot, and does not guarantee that any future therapy will exist or apply to you. If a lawful pathway ever became relevant, participation would run through the trial’s own eligibility process, the FDA’s Expanded Access program, or an approved therapy, and would be decided with a licensed physician. For where the science stands overall, see our emerging research and research areas pages, and for the rules that govern all of this, our FDA regulation hub.